Growth Metrics

Vivos (RDGL) Non-cash Items (2018 - 2025)

Vivos recorded quarterly Non-cash Items of $538960.0 in Q4 2025, up 1004.13% quarter-over-quarter from $48813.0 in Q3 2025, and down 2.41% year-over-year from $552276.0 in Q4 2024.

Vivos' Non-cash Items history runs 8 years deep, the most recent figure standing at $538960.0 for Q4 2025.

  • In Q4 2025, Non-cash Items fell 2.41% year-over-year to $538960.0; the TTM figure through Dec 2025 stood at $1.0 million (down 17.79% YoY), while the FY2025 annual figure was $1.0 million, down 17.79% from the prior year.
  • Non-cash Items came in at $538960.0 for Q4 2025 at Vivos, up from $48813.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.5 million in Q2 2021 to a low of -$57238.0 in Q4 2021.
  • A 5-year average of $337523.2 and a median of $317306.5 in 2022 frame the typical range for Non-cash Items.
  • Across the five-year window, Non-cash Items plunged 125.6% in 2022 and jumped 7643.87% in 2023, its largest moves.
  • Vivos' Non-cash Items stood at -$57238.0 in 2021, then jumped by 840.74% to $423986.0 in 2022, then surged by 44.6% to $613082.0 in 2023, then fell by 9.92% to $552276.0 in 2024, then decreased by 2.41% to $538960.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods registered $538960.0, $48813.0, and $41003.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Vivos - - -3,105.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 538,960.00
Dec 31, 2025 538,960.00
Sep 30, 2025 48,813.00
Sep 30, 2025 48,813.00
Jun 30, 2025 41,003.00
Jun 30, 2025 41,003.00
Mar 31, 2025 379,498.00
Mar 31, 2025 379,498.00
Dec 31, 2024 552,276.00
Dec 31, 2024 552,276.00
Sep 30, 2024 319,006.00
Sep 30, 2024 319,006.00
Jun 30, 2024 148,046.00
Jun 30, 2024 148,046.00
Mar 31, 2024 207,081.00
Mar 31, 2024 207,081.00
Dec 31, 2023 613,082.00
Dec 31, 2023 613,082.00
Sep 30, 2023 445,767.00
Sep 30, 2023 445,767.00
Jun 30, 2023 588,188.00
Jun 30, 2023 588,188.00
Mar 31, 2023 -45,307.00
Mar 31, 2023 -45,307.00
Dec 31, 2022 423,986.00
Dec 31, 2022 423,986.00
Sep 30, 2022 -5,909.00
Sep 30, 2022 -5,909.00
Jun 30, 2022 616,419.00
Jun 30, 2022 616,419.00
Mar 31, 2022 315,607.00
Mar 31, 2022 315,607.00
Dec 31, 2021 -57,238.00
Dec 31, 2021 -57,238.00
Sep 30, 2021 23,082.00
Sep 30, 2021 23,082.00
Jun 30, 2021 1.51 Mn
Jun 30, 2021 1.51 Mn
Mar 31, 2021 85,092.00
Mar 31, 2021 85,092.00
Dec 31, 2020 -63,497.00
Dec 31, 2020 -63,497.00
Sep 30, 2020 -48,330.00
Sep 30, 2020 -48,330.00
Jun 30, 2020 -79,972.00
Jun 30, 2020 -79,972.00
Mar 31, 2020 272,984.00
Mar 31, 2020 272,984.00
Dec 31, 2019 250,881.00
Dec 31, 2019 250,881.00
Sep 30, 2019 484,408.00
Sep 30, 2019 484,408.00
Jun 30, 2019 73,018.00
Jun 30, 2019 73,018.00
Mar 31, 2019 -35,323.00
Mar 31, 2019 -35,323.00
Dec 31, 2018 -26.66 Mn
Dec 31, 2018 -26.66 Mn
Sep 30, 2018 26.84 Mn
Sep 30, 2018 26.84 Mn
Jun 30, 2018 5.96 Mn
Jun 30, 2018 5.96 Mn
Mar 31, 2018 852,884.00
Mar 31, 2018 852,884.00